DE3689144T2 - Pseudorabiesvirus-Protein. - Google Patents

Pseudorabiesvirus-Protein.

Info

Publication number
DE3689144T2
DE3689144T2 DE86307705T DE3689144T DE3689144T2 DE 3689144 T2 DE3689144 T2 DE 3689144T2 DE 86307705 T DE86307705 T DE 86307705T DE 3689144 T DE3689144 T DE 3689144T DE 3689144 T2 DE3689144 T2 DE 3689144T2
Authority
DE
Germany
Prior art keywords
virus protein
pseudorabies virus
pseudorabies
protein
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE86307705T
Other languages
English (en)
Other versions
DE3689144D1 (de
DE3689144T3 (de
Inventor
Erik A Petrovskis
Leonard E Post
James G Timmins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27505761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3689144(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE3689144D1 publication Critical patent/DE3689144D1/de
Publication of DE3689144T2 publication Critical patent/DE3689144T2/de
Application granted granted Critical
Publication of DE3689144T3 publication Critical patent/DE3689144T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
DE3689144T 1985-10-04 1986-10-06 Pseudorabiesvirus-Protein. Expired - Lifetime DE3689144T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78478785A 1985-10-04 1985-10-04
US80179985A 1985-11-26 1985-11-26
US84411386A 1986-03-26 1986-03-26
US88626086A 1986-07-16 1986-07-16

Publications (3)

Publication Number Publication Date
DE3689144D1 DE3689144D1 (de) 1993-11-11
DE3689144T2 true DE3689144T2 (de) 1994-03-03
DE3689144T3 DE3689144T3 (de) 2001-05-17

Family

ID=27505761

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3689144T Expired - Lifetime DE3689144T3 (de) 1985-10-04 1986-10-06 Pseudorabiesvirus-Protein.

Country Status (10)

Country Link
EP (2) EP0238618A1 (de)
JP (2) JP2568384B2 (de)
KR (1) KR880700074A (de)
AU (1) AU601378B2 (de)
CA (1) CA1340848C (de)
DE (1) DE3689144T3 (de)
DK (2) DK175072B1 (de)
ES (1) ES2059305T5 (de)
GR (1) GR3034271T3 (de)
WO (1) WO1987002058A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0261940A3 (de) * 1986-09-23 1989-07-05 Applied Biotechnology, Inc. Pseudorabies-Impfstoffe und DNS-Vektoren zur Rekombination mit Poxviren
US5242829A (en) * 1986-09-23 1993-09-07 Therion Biologics Corporation Recombinant pseudorabies virus
AU616211B2 (en) * 1987-03-09 1991-10-24 Upjohn Company, The Transgenic animal cells resistant to viral infection
US5069901A (en) * 1988-02-03 1991-12-03 Jones Elaine V Preparation of a recombinant subunit vaccine against pseudorabies infection
FR2693472B1 (fr) * 1992-06-26 1994-12-23 Rhone Merieux Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
NL8902414A (nl) * 1989-09-28 1991-04-16 Stichting Centr Diergeneeskund Oligopeptiden/expressieprodukten van het aujeszky's disease virus en daarvoor coderende recombinante polynucleotiden.
JPH06509228A (ja) * 1991-07-17 1994-10-20 コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼイション 改善されたワクチン
US20020193729A1 (en) 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2559384B2 (ja) * 1985-07-29 1996-12-04 ジ・アップジョン・カンパニ− ウイルスワクチン

Also Published As

Publication number Publication date
JP2568384B2 (ja) 1997-01-08
ES2059305T3 (es) 1994-11-16
CA1340848C (en) 1999-12-14
AU6375186A (en) 1987-04-24
JPH07107982A (ja) 1995-04-25
AU601378B2 (en) 1990-09-13
DK288887D0 (da) 1987-06-04
DE3689144D1 (de) 1993-11-11
DK288887A (da) 1987-06-04
EP0223382B2 (de) 2000-06-21
EP0238618A1 (de) 1987-09-30
GR3034271T3 (en) 2000-12-29
WO1987002058A1 (en) 1987-04-09
DK175072B1 (da) 2004-05-24
ES2059305T5 (es) 2000-11-01
JPH08334512A (ja) 1996-12-17
DK35794A (da) 1994-03-29
EP0223382B1 (de) 1993-10-06
KR880700074A (ko) 1988-02-15
JP2638588B2 (ja) 1997-08-06
DE3689144T3 (de) 2001-05-17
EP0223382A1 (de) 1987-05-27

Similar Documents

Publication Publication Date Title
NO863646L (no) Antivirusmiddel.
NO871409L (no) Fusjonsprotein.
DE3684704D1 (de) Perfluorierung von aethern.
FI862430A (fi) Polymerkomposition.
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
DE3680646D1 (de) Sortierung.
ATE50243T1 (de) Fluorbenzylester.
DE3683474D1 (de) Numerisierungsverfahren.
DE3684947D1 (de) Faktor-ix-protein.
DK600586A (da) Protein
NO164392C (no) Fremgangsmaate for forbedring av hydrolysert protein.
FI861691A (fi) En ny tumoerassocierad antigen.
DE3689144T2 (de) Pseudorabiesvirus-Protein.
FI862994A0 (fi) Toppindikator foer frekvensmodulationsmaetanordning.
FI872154A0 (fi) Inaktivering av virus.
DE3681759D1 (de) Abschreckverfahren.
FI861233A (fi) Efterbehandlad prostetisk anordning.
ATE95565T1 (de) Pseudorabiesvirus-protein.
DE3676722D1 (de) Arylsulfon-verbindungen.
DK35694A (da) Pseudorabies-virusprotein
NO864764D0 (no) Vaksine.
NO853777L (no) Kabelakkumulator.
ATE45067T1 (de) Eiweisshydrolysat.
ATE75254T1 (de) Faktor-ix-protein.
FI853917A0 (fi) Foerpackning foer uppspolad produkt.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: PHARMACIA & UPJOHN CO., KALAMAZOO, MICH., US

8366 Restricted maintained after opposition proceedings
8332 No legal effect for de